CLASS III Drug recall · Reported 12 Apr 2017 · FDA Enforcement Report

Ciclopirox Olamine Cream recalled by G & W Laboratories

G & W Laboratories is recalling Ciclopirox Olamine Cream USP, 0.77%, distributed nationwide in the US. The recall was initiated on 20 Mar 2017 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: a) 63800090, Exp 04/17; 63800095, Exp 11/17; 1000573, Exp 02/18; 1002560, Exp 06/18; b) 63800090, Exp 04/17; 63800092, Exp 07/17; 63800093, Exp 08/17; 63800095, Exp 11/17; 1000574, Exp 02/18; 1001772, Exp 05/18; c) 63800089, Exp 03/17; 63800091, Exp 07/17; 63800094, Exp 08/17; 1000842, Exp 01/18; 1000966, Exp 03/18; 1001771, Exp 05/18; 1002562, Exp 06/18.
NDC0713-0638
UPC0307130638159
Quantity recalled230,700 tubes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0636-2017
FDA event ID
76767
Recalling firm
G & W Laboratories, South Plainfield, NJ
Manufacturer
Cosette Pharmaceuticals, Inc.
Classification
Class III
Status
Terminated
Recall initiated
20 Mar 2017
FDA classified
4 Apr 2017
Reported
12 Apr 2017
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Packaging Defects

Timeline

20 Mar 2017Recall initiated by company
4 Apr 2017Classified by FDA+15 days
12 Apr 2017Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15), b) 30 g tubes (NDC 0713-0638-31), and c) 90 g tubes (NDC 0713-0638-18), Rx only, Manufactured by: G&W Laboratories, Inc., South Plainfeld, NJ 07080.

Where it was distributed

Nationwide in the USA and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.

Which lots are affected?

Lot #: a) 63800090, Exp 04/17; 63800095, Exp 11/17; 1000573, Exp 02/18; 1002560, Exp 06/18; b) 63800090, Exp 04/17; 63800092, Exp 07/17; 63800093, Exp 08/17; 63800095, Exp 11/17; 1000574, Exp 02/18; 1001772, Exp 05/18; c) 63800089, Exp 03/17; 63800091, Exp 07/17; 63800094, Exp 08/17; 1000842, Exp 01/18; 1000966, Exp 03/18; 1001771, Exp 05/18; 1002562, Exp 06/18.

Where was it sold?

Nationwide in the USA and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from G & W Laboratories

All 6

Other Ciclopirox Olamine recalls

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIICiclopirox Olamine Cream recalled by G & W LaboratoriesCiclopirox OlamineG & W LaboratoriesPackaging DefectsNationwide